Literature DB >> 16282332

A splicing repressor domain in polypyrimidine tract-binding protein.

Fiona Robinson1, Christopher W J Smith.   

Abstract

Polypyrimidine tract-binding protein (PTB) is an hnRNP with four RRM type domains. It plays roles as a repressive alternative splicing regulator of multilple target genes, as well as being involved in pre-mRNA 3' end processing, mRNA localization, stability, and internal ribosome entry site-mediated translation. Here we have used a tethered function assay, in which a fusion protein of PTB and the bacteriophage MS2 coat protein is recruited to a splicing regulatory site by binding to an artificially inserted MS2 binding site. Deletion mutations of PTB in this system allowed us to identify RRM2 and the following inter-RRM linker region as the minimal region of PTB that can act as splicing repressor domain when recruited to RNA. Splicing repression by the minimal repressor domain remained cell type-specific and dependent upon other defined regulatory elements in the alpha-tropomyosin test minigene. Our results highlight the fact that splicing repression by PTB can be uncoupled from the mode by which it binds to RNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282332     DOI: 10.1074/jbc.M510578200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  A nonsense exon in the Tpm1 gene is silenced by hnRNP H and F.

Authors:  Joel L Coles; Martina Hallegger; Christopher W J Smith
Journal:  RNA       Date:  2008-11-26       Impact factor: 4.942

2.  Post-Translational Modifications in Polypyrimidine Tract Binding Proteins PTBP1 and PTBP2.

Authors:  Jeffrey M Pina; Janice M Reynaga; Anthony A M Truong; Niroshika M Keppetipola
Journal:  Biochemistry       Date:  2018-06-13       Impact factor: 3.162

3.  U1 snRNA directly interacts with polypyrimidine tract-binding protein during splicing repression.

Authors:  Shalini Sharma; Christophe Maris; Frédéric H-T Allain; Douglas L Black
Journal:  Mol Cell       Date:  2011-03-04       Impact factor: 17.970

4.  Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM.

Authors:  Junyi Jiang; Xu Chen; Hao Liu; Jing Shao; Ruihui Xie; Peng Gu; Chaohui Duan
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

5.  Roles of polypyrimidine tract binding proteins in major immediate-early gene expression and viral replication of human cytomegalovirus.

Authors:  Ruth S Cruz Cosme; Yasuhiro Yamamura; Qiyi Tang
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

6.  Combined use of MS2 and PP7 coat fusions shows that TIA-1 dominates hnRNP A1 for K-SAM exon splicing control.

Authors:  Marie-Claude Gesnel; Fabienne Del Gatto-Konczak; Richard Breathnach
Journal:  J Biomed Biotechnol       Date:  2010-01-14

7.  Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB.

Authors:  Miriam Llorian; Schraga Schwartz; Tyson A Clark; Dror Hollander; Lit-Yeen Tan; Rachel Spellman; Adele Gordon; Anthony C Schweitzer; Pierre de la Grange; Gil Ast; Christopher W J Smith
Journal:  Nat Struct Mol Biol       Date:  2010-08-15       Impact factor: 15.369

8.  Repression of alpha-actinin SM exon splicing by assisted binding of PTB to the polypyrimidine tract.

Authors:  Arianne J Matlin; Justine Southby; Clare Gooding; Christopher W J Smith
Journal:  RNA       Date:  2007-06-25       Impact factor: 4.942

9.  The domains of polypyrimidine tract binding protein have distinct RNA structural preferences.

Authors:  Caroline Clerte; Kathleen B Hall
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

10.  Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner.

Authors:  Chen Wang; John T Norton; Supurna Ghosh; Julie Kim; Kazuo Fushimi; Jane Y Wu; M Sharon Stack; Sui Huang
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.